BEVANTOLOL, (R)-

COC1=CC=C(CCNC[C@@H](O)COC2=CC(C)=CC=C2)C=C1OC

InChIKey=HXLAFSUPPDYFEO-QGZVFWFLSA-N

InChI=1S/C20H27NO4/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3/t17-/m1/s1

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

PubMed

Title	Date	PubMed
Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy.	2002 Dec	12541094
Determination of bevantolol in human plasma by high performance liquid chromatography using solid phase extraction technique.	2007 Jul	17703743
Determination of bevantolol enantiomers in human plasma by coupled achiral-chiral high performance-liquid chromatography.	2007 Jul	17457831
Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol.	2007 Jul 12	17628611

Patents

Substance Class	Chemical Created by `admin` on `Sat Dec 16 10:49:02 UTC 2023` Edited by `admin` on `Sat Dec 16 10:49:02 UTC 2023`
Record UNII	34P43RW460
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

BEVANTOLOL, (R)-

Common Name

English

(+)-BEVANTOLOL

Common Name

English

2-PROPANOL, 1-((2-(3,4-DIMETHOXYPHENYL)ETHYL)AMINO)-3-(3-METHYLPHENOXY)-, (2R)-

Systematic Name

English

Code System Code Type Description

CAS

135531-40-7

Created by admin on Sat Dec 16 10:49:02 UTC 2023 , Edited by admin on Sat Dec 16 10:49:02 UTC 2023

PRIMARY

FDA UNII

34P43RW460

Created by admin on Sat Dec 16 10:49:02 UTC 2023 , Edited by admin on Sat Dec 16 10:49:02 UTC 2023

PRIMARY

PUBCHEM

36690919

Created by admin on Sat Dec 16 10:49:02 UTC 2023 , Edited by admin on Sat Dec 16 10:49:02 UTC 2023

PRIMARY

Related Record Type Details


					34ZXW6ZV21

RACEMATE -> ENANTIOMER